115206-02-5

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 115205-90-8 (2S,3S)-3-amino-3-hydroxy-5-methyl-1-phenylhexane 
• 58521-45-2 tert-butoxycarbonyl-L-leucinal 
• 6921-34-2 benzylmagnesium chloride 
• 20312-36-1 L-3-phenyllactic acid 
• 13673-95-5 (S)-methyl 2-hydroxy-3-phenylpropanoate 
• 115205-86-2 (4S,5S)-4-(benzylamino)-5-hydroxy-2-methyl-6-phenyl-1-hexene 
• 115205-84-0 (4S,5S)-4-isobutenyl-3,5-dibenzyloxazolidin-2-one 
• 115205-83-9 (5S)-3,5-dibenzyl-4-ethoxyoxazolidin-2-one 
• 115205-81-7 (S)-2-Benzylcarbamoyloxy-3-phenyl-propionic acid methyl ester 
• 87694-50-6 N-(tert-butoxycarbonyl)-L-leucine-N'-methoxy-N'-methylamide 
• 922722-23-4 (3-methyl-1-phenylacetyl-butyl)-carbamic acid tert-butyl ester 

Downstream Products

• 115206-00-3 (4S,5R)-5-benzyl-4-isobutyloxazolidin-2-one 
• 115206-06-9 (4S,5R)-3-(tert-butoxycarbonyl)-4-isobutyl-5-benzyloxazolidin-2-one 
• 922722-46-1 [(1S,2R)-2-azido-2-benzyl-1-isobutylethyl]carbamic acid tert-butyl ester 
• 922722-42-7 methanesulfonic acid 1-benzyl-2-tert-butoxycarbonylamino-4-methyl-pentyl ester 

Relevant academic research and scientific papers

Rapid discovery and structure-activity profiling of novel inhibitors of human immunodeficiency virus type 1 protease enabled by the copper(I)-catalyzed synthesis of 1,2,3-triazoles and their further functionalization

Building from the results of a computational screen of a range of triazole-containing compounds for binding efficiency to human immunodeficiency virus type 1 protease (HIV-1-Pr), a novel series of potent inhibitors has been developed. The copper(I)-cataly